Custom Health to Go Public with Tech Platform for High-Risk Patients
January 3rd, 2024 By Knowlton Thomas
B.C.-born medical technology innovator Custom Health Inc. is aiming to launch on the New York Stock Exchange through Berenson Acquisition Corp., a special purpose acquisitions company.
Custom Health provides a tech-enabled medication management and healthcare solution, claiming 98% medication adherence for its patients across Canada.
“Guessing with medication must stop,” asserts Shane Bishop, chief executive officer of Custom Health. “We have the expertise, technology, and comprehensive data to help people who take medication achieve the best possible health outcome.”
The Canadian-forged company is focused on serving poly-med patients with chronic conditions—an estimated market of 78 million adults in North America—who often struggle to adhere to prescription regimens, presenting a challenge and cost to the North American healthcare system estimated to be $550 billion per year.
Read the full article here: Custom Health to Go Public with Tech Platform for High-Risk Patients (Techcouver.com)